Strides Alathur facility caters to the US and Other Regulated Markets. The facility manufactures tablets & capsules and supports several current and future products for the US markets.
Headquartered in Bengaluru, Strides Pharma Science operates globally, focusing primarily on regulated markets. The company also follows an ‘in Africa for Africa’ strategy and has an institutional business that services donor-funded markets. Strides Pharma’s manufacturing sites are located across India (Chennai, Puducherry, and Bengaluru), Italy (Milan), Kenya (Nairobi), and the United States (New York). The company claims to focus on ‘difficult to manufacture’ products sold in over 100 countries
As of August 19, 2024, Strides Pharma Science boasts a market capitalisation of Rs 11,885.60 crore and is part of the BSE SmallCap index. Over the last year, the company’s shares have delivered consistent returns, with a year-to-date gain of 97.64 per cent. Over the past year, the stock has surged 212.17 per cent, according to BSE analytics.
Strides Pharma Science shares have a 52-week range of Rs 1,339.90 to Rs 412.45 on the BSE.
As of 02:30 PM on Monday, the stock was trading at Rs 1287.05, down 2.02 per cent from its previous close of Rs 1,313.65 on the BSE. Around 0.34 lakh equity shares worth Rs 4.36 crore were exchanged during the session.
First Published: Aug 19 2024 | 3:00 PM IST
